Sutro Biopharma is a clinical-stage company creating protein-based therapeutics for cancer and autoimmune disorders. They have two product candidates in Phase 1 clinical trials: STRO-001 and STRO-002. The company has partnerships with Merck and Celgene to develop new drugs.